石药集团取得阿瑞匹坦注射液体外释放方法专利

Core Insights - The State Intellectual Property Office of China has granted a patent to Shijiazhuang Yiling Pharmaceutical Co., Ltd. for a method of in vitro release of Aprepitant injection, with the announcement number CN117250269B and application date of August 2023 [1] Company Overview - Shijiazhuang Yiling Pharmaceutical Co., Ltd. was established in 2003 and is located in Shijiazhuang City, focusing primarily on research and experimental development [1] - The company has a registered capital of 39.75 million RMB [1] - According to data from Tianyancha, the company has invested in 6 enterprises, participated in 13 bidding projects, and holds 446 patent records, along with 34 administrative licenses [1]